Loading...
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?
IMPORTANCE: Combination therapies of anti-PD-1 and anti-angiogenesis regimens are emerging rapidly and exhibit more promising anti-tumor efficacy for advanced hepatocellular carcinoma (HCC), and consistently it is the hotspot in clinical studies. OBJECTIVE: To elaborate several issues which are warr...
Na minha lista:
| Udgivet i: | Hepatobiliary Surg Nutr |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8050575/ https://ncbi.nlm.nih.gov/pubmed/33898559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn-2021-7 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|